The in vitro and in vivo evaluation of SSTR2/CXCR4 mAbs-EV-Ver-A/DM1 showed high NET-specific targeting and high efficacy to inhibit tumor growth in xenograft mouse model. This evidence concerns the gene CXCR4 and neoplasm.